Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach

Journal of Addiction Medicine and Therapeutic Science
Research Article
Abstract 
Background: Methamphetamine abuse and dependence is currently a considerable problem. Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving. Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving. Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature. Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.
http://www.peertechz.com/Addiction-Medicine-Therapeutic-Science/pdf/JAMTS-2-111.pdf

Comments

Popular posts from this blog

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Case Report: Reynolds Syndrome

Apparent Digestibility and Utilization of Protein and Phosphorus in diets of incorporated with Sprouted Sorghum, Phytase and Protease Enzymes for African Catfi sh (Clarias gariepinus)